SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-171564
Filing Date
2024-06-28
Accepted
2024-06-28 10:10:54
Documents
19
Period of Report
2024-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d756853d8k.htm   iXBRL 8-K 28747
2 EX-1.1 d756853dex11.htm EX-1.1 233853
3 EX-5.1 d756853dex51.htm EX-5.1 9752
4 EX-99.1 d756853dex991.htm EX-99.1 9614
8 GRAPHIC g756853dsp001.jpg GRAPHIC 15918
9 GRAPHIC g756853g0628085622558.jpg GRAPHIC 4141
10 GRAPHIC g756853g0628105633594.jpg GRAPHIC 4954
  Complete submission text file 0001193125-24-171564.txt   506682

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA svra-20240627.xsd EX-101.SCH 2865
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20240627_lab.xml EX-101.LAB 17235
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20240627_pre.xml EX-101.PRE 10822
23 EXTRACTED XBRL INSTANCE DOCUMENT d756853d8k_htm.xml XML 3543
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 241082011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)